New Millennium Group’s Medtronic MDT Stock Holding History

New Millennium Group’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$490	Sell	5 -6	-55%	-$583	﹤0.01%	355
2025 Q3	$1.06K	Sell	11 -69	-86%	-$6.34K	﹤0.01%	348
2025 Q2	$7K	Sell	80 -66	-45%	-$5.6K	﹤0.01%	223
2025 Q1	$13.1K	Buy	146 +8	+6%	+$716	0.01%	181
2024 Q4	$11K	Sell	138 -1	-0.7%	-$87	0.01%	214
2024 Q3	$12.6K	Sell	139 -31	-18%	-$2.61K	0.01%	162
2024 Q2	$13.4K	Sell	170 -32,215	-99%	-$2.64M	0.01%	165
2024 Q1	$2.82M	Buy	32,385 +5,098	+19%	+$435K	2.13%	13
2023 Q4	$2.25M	Buy	27,287 +27,265	+123,932%	+$2.08M	1.99%	12
2023 Q3	$1.74K	Hold	22	–	–	﹤0.01%	304
2023 Q2	$1.94K	Hold	22	–	–	﹤0.01%	305
2023 Q1	$1.76K	Hold	22	–	–	﹤0.01%	327
2022 Q4	$1.68K	Buy	22 +1	+5%	+$81	﹤0.01%	333
2022 Q3	$2K	Hold	21	–	–	﹤0.01%	296
2022 Q2	$2K	Buy	+21	New	+$2.13K	﹤0.01%	295

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

New Millennium Group's MDT Position: Q4 2025 in Review

New Millennium Group reduced its Medtronic (MDT) stake by 55% in Q4 2025, selling an estimated $583 and leaving 5 shares worth $490. The position accounts for ﹤0.01% of the portfolio, ranked #355.

New Millennium Group first reported a position in MDT in Q2 2022 and has held it in 15 quarters since. The position peaked at $2.82M in Q1 2024. 2,303 funds tracked by Wall St. Rank hold MDT as of Q4 2025.

New Millennium Group held 5 shares of Medtronic worth $490 as of Q4 2025.
New Millennium Group sold 6 Medtronic shares in Q4 2025, an estimated $583.
Medtronic made up ﹤0.01% of New Millennium Group's portfolio in Q4 2025, its #355 holding.
New Millennium Group first reported a position in Medtronic in Q2 2022 and has held it in 15 quarters since.
New Millennium Group's Medtronic position peaked at $2.82M in Q1 2024.
2,303 funds tracked by Wall St. Rank held Medtronic as of Q4 2025.

Based on New Millennium Group's 13F filing for Q4 2025, filed 6 Feb 2026.